An Open-label, Multi-center, Expanded Access Study of Pasireotide s.c. in Patients With Cushing's Disease.
Status:
Completed
Trial end date:
2017-01-26
Target enrollment:
Participant gender:
Summary
This study provided access to pasireotide sc in patients with Cushing's disease.and provided
additional information for safety and efficacy of pasireotide s.c.